Drug
SM-1
SM-1 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Phase Distribution
Ph phase_2
2
50%
Ph phase_3
2
50%
Phase Distribution
0
Early Stage
2
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Withdrawn1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 22 (50.0%)
Phase 32 (50.0%)
Trials by Status
completed250%
withdrawn125%
not_yet_recruiting125%
Recent Activity
0 active trials
Showing 4 of 4
withdrawnphase_3
An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia
NCT03338764
not_yet_recruitingphase_2
SM-1 vs. an Active Comparator in A Model of Transient Insomnia
NCT04396327
completedphase_3
SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.
NCT03331042
completedphase_2
Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia
NCT02671760
Clinical Trials (4)
Showing 4 of 4 trials
NCT03338764Phase 3
An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia
NCT04396327Phase 2
SM-1 vs. an Active Comparator in A Model of Transient Insomnia
NCT03331042Phase 3
SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.
NCT02671760Phase 2
Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4